OPEN END TURBO BULL OPTIONSSCHEIN - ASTRAZENECA | Delayed Deutsche Boerse AG 01:36:43 2024-07-16 pm EDT | ||
| 4.84 EUR | +1.04% |
|
| Current month | -6.20% | ||
| 1 month | -10.54% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 4.84 | +1.04% |
| 24-07-15 | 4.79 | -4.96% |
| 24-07-12 | 5.04 | +4.56% |
| 24-07-11 | 4.82 | +0.63% |
| 24-07-10 | 4.79 | +1.48% |
Delayed Quote Deutsche Boerse AG
Last update July 16, 2024 at 01:36 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | ASTRAZENECA PLC |
| Issuer | 
UniCredit
|
| WKN | HR6WZG |
| ISIN | DE000HR6WZG6 |
| Date issued | 2021-04-16 |
| Strike | 8,029 p |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.57 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.6 € |
|---|---|
| Lowest since issue | 0.47 € |
| Spread | 0.04 € |
| Spread % | 0.82% |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
156.8
USD
Average target price
177.6
USD
Spread / Average Target
+13.29%
- Stock Market
- Certificates
- Certificat
